Macular degeneration treatment in India is far more affordable than in the US, UK, or other Western countries, while still using the same globally trusted drugs and technology. Here’s the quick picture:
Below, we break down everything in simple language: what macular degeneration is, the treatment options, exact cost ranges, city-wise pricing, insurance coverage, and how to save money without compromising care.
Macular degeneration is an eye condition that damages the macula — the small central part of your retina responsible for sharp, detailed vision (the vision you use for reading, recognising faces, and driving).
It doesn’t cause total blindness, but it destroys central vision, making everyday tasks difficult.
There are two main types:
Macular degeneration mostly affects people over 50 and is one of the leading causes of vision loss in older adults worldwide.
This is the gold-standard treatment. A medicine is injected directly into the eye (intravitreal injection) to block a protein called VEGF, which causes abnormal, leaky blood vessels to grow. Stopping VEGF slows or stops vision loss, and in many patients, improves vision.
Four main drugs are used in India:
Drug | Type | Typical Cost per Injection (India) |
Avastin (Bevacizumab) | Off-label cancer drug, repurposed for eyes | ₹1,500 – ₹25,000 |
Lucentis (Ranibizumab) | FDA-approved, eye-specific | ₹25,000 – ₹45,000 |
Eylea (Aflibercept) | FDA-approved, longer-lasting dosing | ₹25,000 – ₹45,000 |
Beovu (Brolucizumab) | Newer FDA-approved option | ₹27,000 – ₹35,000 |
Anti-VEGF therapy in India is significantly more affordable than in Western countries, with per-injection costs ranging from ₹5,000 to ₹45,000 depending on the medication used.
Bevacizumab (Avastin) is used widely due to its affordability and accounts for 70–80% of anti-VEGF injections given in India.
Why the big price gap between drugs? Avastin was originally developed as a cancer drug and is used “off-label” for eyes, which keeps it cheap. Lucentis and Eylea are specifically approved and packaged for eye use, so they cost more — though many studies show Avastin works just as well for most patients.
How many injections will you need? This varies by patient. Some people need injections monthly for the first 3 months, then less often (every 2–3 months) as the condition stabilises. Others may need long-term maintenance dosing over years. This is the single biggest factor affecting your total treatment cost.
A light-sensitive drug is injected into the bloodstream, then activated with a laser to seal off leaking blood vessels in the eye. Used less often today since anti-VEGF injections are usually more effective, but still an option in specific cases.
A more traditional laser treatment that seals leaking blood vessels using heat. This is one of the surgical interventions used in India for macular degeneration, alongside vitrectomy, photodynamic therapy, retinal implants, and macular translocation surgery.
In advanced or complicated cases, surgery may be needed to remove damaged vitreous gel or abnormal blood vessels, or in rare cases, to reposition the macula itself (macular translocation surgery). These procedures are more invasive and cost more than injections.
For patients with significant vision loss, magnifying devices, specialised lighting, and vision rehabilitation training help make daily life easier. This isn’t a cure but improves quality of life.
There’s no treatment that reverses dry macular degeneration. If caught early, doctors typically recommend vitamin and mineral supplements (such as AREDS2 formulations), a healthy diet, quitting smoking, and regular monitoring to slow progression. Costs here are mainly consultation and supplement expenses, which are far lower than wet AMD treatment.
Treatment | Approximate Cost (INR) | Approximate Cost (USD) |
Single Avastin injection | ₹1,500 – ₹25,000 | $18 – $300 |
Single Lucentis/Eylea injection | ₹25,000 – ₹45,000 | $300 – $540 |
Full injection course (multiple sessions) | ₹1,00,000 – ₹4,00,000+ | $1,200 – $4,800+ |
Macular degeneration surgery (general) | ₹1,25,000 – ₹2,10,000 | $1,500 – $2,500 |
Macular degeneration surgery (complex cases) | ₹2,60,000 – ₹10,00,000 | $3,100 – $12,000 |
Stem cell therapy for macular degeneration | ₹3,30,000 – ₹7,00,000 | $4,000 – $8,500 |
Overall average treatment package | ₹3,00,000 – ₹3,20,000 | $3,500 – $4,000 |
Note: Stem cell therapy for AMD is still considered experimental in most parts of the world and isn’t a standard, universally recommended treatment. Always discuss evidence-based options with a qualified retina specialist first.
Costs vary meaningfully by city due to differences in hospital infrastructure, doctor consultation fees, and local overheads.
Metro cities like Mumbai, Delhi, and Bangalore tend to sit at the higher end, while tier-2 cities are generally more budget-friendly for comparable quality of care. Here’s an indicative comparison:
City | Single Anti-VEGF Injection (Avastin) | Single Anti-VEGF Injection (Lucentis/Eylea) | Full Treatment/Surgery Package |
Mumbai | ₹5,000 – ₹25,000 | ₹30,000 – ₹45,000 | ₹1,50,000 – ₹4,50,000 |
Delhi NCR | ₹5,000 – ₹22,000 | ₹28,000 – ₹45,000 | ₹1,50,000 – ₹4,00,000 |
Bangalore | ₹4,000 – ₹20,000 | ₹27,000 – ₹42,000 | ₹1,40,000 – ₹4,00,000 |
Hyderabad | ₹4,000 – ₹18,000 | ₹25,000 – ₹40,000 | ₹1,25,000 – ₹3,50,000 |
Chennai | ₹4,000 – ₹18,000 | ₹25,000 – ₹40,000 | ₹1,25,000 – ₹3,50,000 |
Pune | ₹3,500 – ₹16,000 | ₹24,000 – ₹38,000 | ₹1,20,000 – ₹3,25,000 |
Kolkata | ₹3,000 – ₹15,000 | ₹22,000 – ₹35,000 | ₹1,10,000 – ₹3,00,000 |
Ahmedabad | ₹3,000 – ₹15,000 | ₹22,000 – ₹35,000 | ₹1,10,000 – ₹3,00,000 |
Tier-2 cities (Jaipur, Nagpur, Kochi, etc.) | ₹1,500 – ₹12,000 | ₹20,000 – ₹32,000 | ₹1,00,000 – ₹2,75,000 |
These figures are indicative averages meant to give you a general sense of city-wise positioning. Metro hospitals with international accreditation (JCI/NABH) and senior retina specialists often price at the higher end of these ranges. Always request a written, itemised quote from the specific hospital you’re considering, since actual prices can vary by clinic even within the same city.
The cost gap looks large because it depends heavily on:
1.Which drug is used – Avastin vs. Lucentis/Eylea/Beovu makes the biggest difference.
2.Number of injections needed – some patients need 3, others need ongoing injections for years.
3.City and hospital – metro cities like Mumbai, Delhi, Bangalore, and Chennai, and premium hospital chains, generally charge more than tier-2 cities like Pune, Jaipur, Kochi, and Nagpur.
4.Diagnostic tests – OCT (Optical Coherence Tomography) scans, fluorescein angiography, and retinal imaging add to the bill, especially at the start of treatment and during follow-ups.
5.Doctor’s expertise – senior retina specialists at top institutes may charge higher consultation and procedure fees.
6.Type and stage of AMD – wet AMD (needing injections/surgery) costs significantly more than dry AMD (mainly monitoring and supplements).
7.Whether it’s a single procedure or surgery package – many hospitals bundle pre-surgical investigations, hospitalization, surgery, nursing, medicines, and anesthesia into one treatment package, which changes the total quote significantly.
A typical macular degeneration treatment package in India may include:
Always ask your hospital for an itemised cost breakdown rather than a single lump-sum figure, so you know exactly what you’re paying for.
Macular degeneration treatment is typically covered under major medical health insurance plans rather than standalone vision insurance plans, since it’s classified as a medical eye disease rather than a routine vision correction issue. However:
1.Ask about Avastin as a first option. It’s significantly cheaper than Lucentis or Eylea and has similar effectiveness for many patients — discuss this directly with your retina specialist.
2.Compare across cities, not just hospitals. If you have flexibility, tier-2 cities like Pune, Kochi, or Nagpur often offer comparable quality at lower prices than Mumbai or Delhi.
3.Get multiple hospital quotes. Prices for the same injection or surgery can vary noticeably between hospitals in the same city.
4.Check government and NGO-run eye hospitals. Some offer subsidised rates for anti-VEGF injections and eye surgeries.
5.Clarify your insurance coverage in advance to avoid surprise out-of-pocket expenses.
6.Don’t skip early diagnosis. Catching AMD early — especially dry AMD — can slow progression with cheaper interventions like supplements, avoiding the need for costlier treatment later.
7.Ask about package deals for multi-injection treatment courses, which some hospitals offer at a discount versus paying per session.
1.What is the average cost of macular degeneration treatment in India? A full treatment course in India typically costs around USD 3,500–4,000 (roughly INR 3,00,000–3,20,000), though this can be lower or higher depending on the city, drug, and number of injections needed.
2.How much does a single eye injection cost in India? It ranges from about ₹1,500 for Avastin up to ₹45,000 for Lucentis, Eylea, or Beovu, per injection — with metro cities like Mumbai and Delhi typically at the higher end and tier-2 cities at the lower end.
3.Is treatment cheaper in Pune or Hyderabad compared to Mumbai? Generally yes. Pune and Hyderabad tend to have somewhat lower consultation and procedure costs than Mumbai or Delhi NCR, while still offering good-quality retina care, though the exact difference depends on the specific hospital chosen.
4.Is dry AMD treatment cheaper than wet AMD treatment? Yes. Dry AMD has no injection-based cure, so costs are limited to consultations, supplements, and monitoring — much less than the ongoing injection costs for wet AMD.
5.How many injections will I need for wet AMD? This varies by patient. A common pattern is monthly injections for the first 3 months, followed by injections every 2–3 months, but some patients need long-term ongoing treatment. Your retina specialist will determine the exact schedule based on how your eye responds.
6.Does insurance cover macular degeneration treatment in India? Often yes, under general health insurance (not vision-only plans), but coverage depends on your specific policy. Confirm details with your insurer beforehand.
7.Is stem cell therapy a proven treatment for macular degeneration? Not yet. It’s still considered experimental and isn’t part of standard, globally accepted treatment guidelines. Discuss risks and evidence with your doctor before considering it.
8.Can macular degeneration be fully cured? No. There’s currently no complete cure for either dry or wet AMD. Treatment aims to slow progression, prevent further vision loss, and in some wet AMD cases, improve vision — not reverse the underlying condition.
9.Which cities in India offer the best and most affordable macular degeneration treatment? Major metro cities — Delhi NCR, Mumbai, Bangalore, Chennai, Hyderabad, and Pune — have well-established retina care centres with international accreditation, though tier-2 cities may offer lower prices for similar quality care.
Macular degeneration treatment in India offers a strong combination of affordability and quality, making it accessible for both Indian patients and international medical tourists.
Costs can range from a few thousand rupees for a single Avastin injection to several lakhs for a complete surgical or long-term injection treatment plan, and vary meaningfully depending on which city and hospital you choose.
The right cost for you will depend on the type and stage of your AMD, the drug your doctor recommends, your city, and how many treatment sessions you need.
Important: This article is for general informational purposes and isn’t a substitute for professional medical advice. Please consult a qualified ophthalmologist or retina specialist for an accurate diagnosis, treatment plan, and personalised cost estimate.
If you’re experiencing symptoms of vision loss, blurred or distorted central vision, or difficulty recognising faces, don’t delay — book an eye examination with a retina specialist as soon as possible. Early diagnosis significantly improves treatment outcomes.
Appointment Form
AUTHOR
Ophthalmologist/ Eye Surgeon 13+ Years Exp
MBBS, MS – Ophthalmology
CONDITION
CALL US 24/7 FOR ANY HELP
GET IN TOUCH ON
Appointment Form
Saijyothi Eye Hospital, where excellence meets compassion. Founded by the esteemed Dr. Saibaba Goud, M.S., Ph.D., Padma Shri Awardee, our institution stands as a beacon of hope for those seeking exceptional eye care. Dr. Saibaba Goud’s vision goes beyond restoring sight, aiming to transform lives. At Saijyothi Eye Hospital, we offer exceptional care, from routine eye exams to advanced surgeries, with personalized services tailored to each patient’s needs.